Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Cancer Cytopathology
|
July 29, 2020
A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens
Lukas Bubendorf, Esther Conde, Federico Cappuzzo, et al.
Communications Biology
|
October 1, 2025
The critical human pathogen Acinetobacter baumannii exhibits light-regulated circadian rhythms
Valentín Permingeat, Bárbara Edith Perez Mora, María Laura Migliori, et al.
The Pediatric Infectious Disease Journal
|
October 27, 2004
Diarrhea morbidity and mortality in Mexican children: impact of rotavirus disease
F Raúl Velázquez, Herlinda Garcia-Lozano, Esteban Rodriguez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 10, 2021
Expanding the Pie-Differentiated PrEP Delivery Models to Improve PrEP Uptake in the San Francisco Bay Area
Erin C Wilson, Caitlin M Turner, Christina Sanz-Rodriguez, et al.
International Journal of Molecular Sciences
|
July 29, 2023
miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients
Darío Sanchez-Cabrero, Álvaro Garcia-Guede, Miranda Burdiel, et al.
NPJ Vaccines
|
January 5, 2021
MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
Andrew D White, Laura Sibley, Charlotte Sarfas, et al.
Theranostics
|
November 22, 2017
DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through <i>MAFG</i> Overexpression in Cancer Cells
Olga Vera, Julia Jimenez, Olga Pernia, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
July 28, 2018
MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species
Olga Vera-Puente, Carlos Rodriguez-Antolin, Ana Salgado-Figueroa, et al.
Ebiomedicine
|
March 18, 2025
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting
Michele Tameris, Virginie Rozot, Claire Imbratta, et al.
JTO Clinical and Research Reports
|
March 25, 2024
<i>RET</i> Fusion Testing in Patients With NSCLC: The RETING Study
Esther Conde, Susana Hernandez, Jose Luis Rodriguez Carrillo, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Cancer Cytopathology
|
July 29, 2020
A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens
Lukas Bubendorf, Esther Conde, Federico Cappuzzo, et al.
Communications Biology
|
October 1, 2025
The critical human pathogen Acinetobacter baumannii exhibits light-regulated circadian rhythms
Valentín Permingeat, Bárbara Edith Perez Mora, María Laura Migliori, et al.
The Pediatric Infectious Disease Journal
|
October 27, 2004
Diarrhea morbidity and mortality in Mexican children: impact of rotavirus disease
F Raúl Velázquez, Herlinda Garcia-Lozano, Esteban Rodriguez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 10, 2021
Expanding the Pie-Differentiated PrEP Delivery Models to Improve PrEP Uptake in the San Francisco Bay Area
Erin C Wilson, Caitlin M Turner, Christina Sanz-Rodriguez, et al.
International Journal of Molecular Sciences
|
July 29, 2023
miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients
Darío Sanchez-Cabrero, Álvaro Garcia-Guede, Miranda Burdiel, et al.
NPJ Vaccines
|
January 5, 2021
MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
Andrew D White, Laura Sibley, Charlotte Sarfas, et al.
Theranostics
|
November 22, 2017
DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through <i>MAFG</i> Overexpression in Cancer Cells
Olga Vera, Julia Jimenez, Olga Pernia, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
July 28, 2018
MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species
Olga Vera-Puente, Carlos Rodriguez-Antolin, Ana Salgado-Figueroa, et al.
Ebiomedicine
|
March 18, 2025
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting
Michele Tameris, Virginie Rozot, Claire Imbratta, et al.
JTO Clinical and Research Reports
|
March 25, 2024
<i>RET</i> Fusion Testing in Patients With NSCLC: The RETING Study
Esther Conde, Susana Hernandez, Jose Luis Rodriguez Carrillo, et al.
Page
of 4